Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 4Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Colonic Neoplasms 1Choriocarcinoma 1Cholangiocarcinoma 1Breast Neoplasms, Male 1Bone Neoplasms 1Bone Diseases 1

Interventions

Flow Cytometry 3Cyclophosphamide 3Radiotherapy 2Methylprednisolone 2Interviews as Topic 2Immunologic Techniques 2Alemtuzumab 2sargramostim 1saracatinib 1resiquimod 1poly ICLC 1orantinib 1motexafin gadolinium 1liposomal doxorubicin 1fludarabine phosphate 1flt3 ligand protein 1dexamethasone acetate 1dexamethasone 21-phosphate 1cediranib 1aldesleukin 1Thrombopoietin 1Thiotepa 1Therapeutics 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Factor 1Psychiatric Rehabilitation 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × saracatinib × Breast × Clear all
NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
40 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡